Insider Trading: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

3.14CAD
24 May 2013
Price Change (% chg)

$0.04 (+1.29%)
Prev Close
$3.10
Open
$3.10
Day's High
$3.19
Day's Low
$3.05
Volume
12,499
Avg. Vol
4,476
52-wk High
$3.72
52-wk Low
$1.74

Search Stocks
SCHULER JACK W Options Exercised: 0
Trade Date: Monday, 21 Nov 2011 Price: 1.35
Title: Beneficial Owner of More than 10% Class Shares Held: 2,823,010
Type Traded: Direct Net Change in Shares This Filing: 1,925,926

Institutional Holders

% Shares Owned: 27.91%
# of Holders: 21
Total Shares Held: 7,514,643
3 Mo. Net Change: -435,722
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 10
# Net Buyers: -5

Officers & Directors

Name Age Since Current Position

Tony Cruz

59 1999 Chairman of the Board, Chief Executive Officer

Nicole Rusaw-George

39 2012 Chief Financial Officer

Bruce Connop

43 2012 Vice President - Non-Clinical & Pharmaceutical Development

Aleksandra Pastrak

46 2011 Vice President - Clinical Development and Medical Officer

Carl Damiani

39 2007 Vice President - Business Development

Louis Alexopoulos

1998 Secretary

Michael Ashton

66 2012 Lead Independent Director

Paul Baehr

69 2002 Independent Director

Christopher Henley

52 2000 Independent Director

Gary Pace

2012 Independent Director
Search Stocks